Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. (“Sernova” or the “Company”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company...
-
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced the winners of its 2026 Partner of the Year...
-
VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and...
-
Beghou Adds New Partners to Advance Integrated, Experience-Driven Commercialization in Life Sciences
Beghou adds new partners Jenny Herritz and Marcos Mendell to help drive more connected, experience-driven life sciences commercialization efforts.
-
Austin, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Agentive AI in Healthcare Market Size & Growth Analysis According to SNS Insider, the global Agentive AI in Healthcare Market was valued at USD 538.56...
-
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- SVA APP Bolivia (SVA APP BOL) has announced plans to launch its Initial Public Offering (IPO), marking a new milestone in the company’s history and a...
-
Brooklyn, New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Brooklyn, NY – September 30th – In celebration of The New Yorker’s landmark 100th anniversary this year, Brooklyn Brewery is excited to...
-
LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon...
-
DVCon U.S. 2025 Announces Call for Contributions
-
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...